Related Experiment Video
Updated: May 18, 2026

CAPRRESI: Chimera Assembly by Plasmid Recovery and Restriction Enzyme Site Insertion
Published on: June 25, 2017
Construction of chimeric E3s expression plasmids targeting oncoprotein ras
Yi-hui Ma1, Qiang Zhang, Yu-mei Gu
1Department of Pathology, PUMC Hospital, CAMS and PUMC, Beijing, China.
Objective:
To construct certain chimeric E3s expression plasmids targetting oncoprotein Ras by harnessing the theory of protein knockdown.
Methods:
We chose the binding domain of Raf-1, PI3K, RalGDS, and the function domain of F-Box as well as the U-Box to construct the plasmids. Then used the double enzyme, PCR, and sequence to test the validity and integrity of the cloned nucleotide fragments. The expression efficiency of the plasmids in eukaryotic cells was detected by Western blot analysis.
Results:
Five of 6 plasmids in this study expressed the corresponding fusion proteins in HEK293T cells, and (RBD+CRD)(Raf-1)- U-Box-pcDNA3.1 can knocked down the protein level of Ras in PANC-1 cells.
Conclusions:
We successfully constructed the chimeric E3 expression plasmids, which provides a solid basis for further research on protein knockdown.
Insights
Researchers developed novel chimeric E3 expression plasmids to target and reduce oncoprotein Ras levels. This protein knockdown strategy offers a new avenue for cancer research and therapeutic development.
Area of Science:
- Molecular Biology
- Oncology
- Biotechnology
Background:
- Oncoprotein Ras plays a critical role in various cancers.
- Targeting Ras for protein knockdown is a promising therapeutic strategy.
- Developing efficient expression systems for protein knockdown is essential.
Purpose of the Study:
- To construct chimeric E3 ubiquitin ligase (E3) expression plasmids targeting oncoprotein Ras.
- To utilize protein knockdown theory for Ras inhibition.
- To create a foundation for further research in Ras-targeted therapies.
Main Methods:
- Chimeric E3 plasmids were engineered using specific binding and functional domains (Raf-1, PI3K, RalGDS, F-Box, U-Box).
- Plasmid integrity and nucleotide fragment cloning were validated using double enzyme digestion, PCR, and sequencing.
- Expression efficiency in eukaryotic cells (HEK293T) was assessed via Western blot analysis.
Main Results:
- Five out of six constructed plasmids successfully expressed fusion proteins in HEK293T cells.
- The plasmid (RBD+CRD)(Raf-1)-U-Box-pcDNA3.1 demonstrated the ability to effectively knock down Ras protein levels in PANC-1 cells.
Conclusions:
- Novel chimeric E3 expression plasmids targeting Ras were successfully constructed.
- These plasmids provide a robust platform for investigating protein knockdown strategies against Ras.
- This research lays the groundwork for developing new cancer treatments focused on Ras inhibition.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
The Ras Gene
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Abnormal Proliferation
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

